Whalesbook
Sun Pharmaceutical Industries has secured a significant legal victory, winning a decade-long trademark infringement battle. The Bombay High Court has issued a definitive order prohibiting a Navi Mumbai-based drug manufacturer from using the brand names 'Absun' and 'Absun Pharma'. The court's decision firmly supports Sun Pharma's long-standing 'Sun' and 'Sun Pharma' marks.
Justice Manish Pitale stated in his order that the addition of just the alphabets 'AB' as a prefix to Sun Pharma's registered trademarks does not create a distinct mark. The court found the rival names 'Absun' and 'Absun Pharma' to be deceptively similar, visually, structurally, and phonetically, to Sun Pharma's registered trademarks. The ruling emphasized that the defendant's trade names effectively subsume Sun Pharma's proprietary marks.
The legal challenge was initiated by Dilip Sanghvi-promoted Sun Pharmaceutical Industries in 2013. The company argued that the defendant's brand names were too close to its own registered trademarks, which are critical for medicinal and pharmaceutical preparations. Sun Pharma presented evidence of its 'Sun' trademark registration dating back to 1983, with user claims originating in 1978. The company's counsel contended that a strict approach is necessary to prevent consumer confusion in the pharmaceutical sector.
This legal triumph underscores Sun Pharma's commitment to protecting its intellectual property and brand identity in the competitive pharmaceutical market.